{"entity":{"id":"nct05935748","kind":"trial","name":"Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)","aka":[],"tldr":"A phase 2 trial of NKT2152 run by NiKang Therapeutics, Inc., terminated.","summary":"Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) is a phase 2 interventional study registered as NCT05935748 by NiKang Therapeutics, Inc., with 18 participants enrolled, started 2023-07-28, primary completion reached 2025-06-30. Conditions recorded: ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer, Kidney Neoplasms, Renal Cancer, Renal Neoplasms, Recurrent Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Refractory Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, Carcinoma, Neoplasms, Carcinoma, Renal Cell, Neoplasms, Glandular and Epithelial, Neoplasm by Histology, Adenocarcinoma, Urologic Neoplasms, Urogenital Neoplasms, Neoplasms by Site, Kidney Diseases, Urologic Diseases. Interventions recorded: NKT2152, palbociclib, sasanlimab. Reason given for stopping: This study was terminated as a result of Sponsor portfolio reprioritization.","status":"historic","asOf":"2026-11-04","links":[{"label":"ClinicalTrials.gov NCT05935748","url":"https://clinicaltrials.gov/study/NCT05935748"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["clear-cell-rcc"],"sections":[],"technologies":[],"targets":[],"drugs":["nkt2152"],"companies":["nikang-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05935748","phase":"2","setting":"A Phase 2 Trial to Evaluate the Safety and Efficacy of NKT2152 in Combination With Palbociclib (Doublet) and With Palbociclib and Sasanlimab (Triplet) in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma","sponsor":"NiKang Therapeutics, Inc.","enrolled":18,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05935748/","neighbours":{"cancer":[{"id":"clear-cell-rcc","kind":"cancer","name":"Clear cell renal cell carcinoma","route":"/cancers/clear-cell-rcc/"}],"drug":[{"id":"nkt2152","kind":"drug","name":"NKT2152","route":"/drugs/nkt2152/"}],"company":[{"id":"nikang-therapeutics","kind":"company","name":"NiKang Therapeutics","route":"/companies/nikang-therapeutics/"}]}}